missing translation for 'onlineSavingsMsg'
Learn More

DLL3 Antibody (DLL3/9361), Novus Biologicals™

Mouse Monoclonal Antibody

256.00 € - 484.00 €

Specifications

Antigen DLL3
Clone DLL3/9361
Concentration 0.2 mg/ml
Applications Immunohistochemistry
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30293595
View Documents
Novus Biologicals
NBP3-44583-20ug
20 μg
256.00 €
20µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30290748
View Documents
Novus Biologicals
NBP3-44583-100ug
100 μg
484.00 €
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

DLL3 Monoclonal antibody specifically detects DLL3 in Human samples. It is validated for Immunohistochemistry
Specifications

Specifications

DLL3
0.2 mg/ml
Monoclonal
Purified
RUO
Human
delta (Drosophila)-like 3, Delta3, delta-like 3 (Drosophila), delta-like protein 3, Drosophila Delta homolog 3, SCDO1delta3
Recombinant fragment (around aa400-618) of human DLL3 protein (Uniprot: Q9NYJ7). Exact sequence is proprietary.
Primary
Store at 4⪚C.
DLL3/9361
Immunohistochemistry
Unconjugated
Mouse
Cell Biology, Cell Cycle and Replication, Neuroscience
10 mM PBS with 0.05% BSA
10683
IgG2c κ
Protein A or G purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.